MRC1 and neoplasm: As expected, the “aCD47/Ce6@PPG + L” group exhibited the strongest ability to upregulate M1-like TAMs (CD80+CD11b+F4/80+) and downregulate M2-like TAMs (CD206+CD11b+F4/80+) in tumor tissues (Fig. 6e–g).